LeAnn Boyd Joins Presenters at Women Leaders in Healthcare Conference

14th Annual Modern Healthcare event honors top female healthcare executives

LeAnn Boyd, CEO, joins top female executives from across the nation at the Women Leaders in Healthcare Conference, July 16 in Chicago. Taking the stage for the session, “Finding the Right Work-Life Balance,” LeAnn will share insights that help women navigate personal and professional challenges.

Selected by Modern Healthcare as one of its Women Leaders for 2024, LeAnn Boyd  is among an elite group of influential women working to improve the patient experience while advancing the objectives of their own organizations. Modern Healthcare annually celebrates outstanding contributions of women across the industry, highlighting their efforts to improve care delivery, promote health equity, shape policy and advance gender equality in healthcare leadership.

LeAnn Boyd said,

“Navigating a business landscape that is constantly changing, Liviniti is at the forefront of creative solutions for the pharmacy industry. On this journey, I am proud to lead a company embracing diversity and promoting career advancement for all – especially up-and-coming women leaders. I am honored to be among the group of exceptional women named to Modern Healthcare’s Women Leaders, 2024.”

The 14th annual Women Leaders in Healthcare Conference and Awards Luncheon offers opportunities for community building, empowerment, and personal and professional growth to established and emerging women leaders from all corners of healthcare. The event strives to build a community of leaders through thought-provoking content and unique networking opportunities.

SourceLiviniti

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”